151 related articles for article (PubMed ID: 17626074)
1. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
Mainou BA; Everly DN; Raab-Traub N
J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
[TBL] [Abstract][Full Text] [Related]
2. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
Hatton O; Lambert SL; Krams SM; Martinez OM
PLoS One; 2012; 7(8):e42610. PubMed ID: 22880054
[TBL] [Abstract][Full Text] [Related]
3. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.
Vaysberg M; Hatton O; Lambert SL; Snow AL; Wong B; Krams SM; Martinez OM
J Biol Chem; 2008 Dec; 283(52):36573-85. PubMed ID: 18986987
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
Luftig M; Prinarakis E; Yasui T; Tsichritzis T; Cahir-McFarland E; Inoue J; Nakano H; Mak TW; Yeh WC; Li X; Akira S; Suzuki N; Suzuki S; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15595-600. PubMed ID: 14673102
[TBL] [Abstract][Full Text] [Related]
7. Enhancive effect of N,N'-dinitrosopiperazine on inducing precancerous lesion on nasal and/or nasopharyngeal epithelia of TgN(p53mt-LMP1)/HT mice.
Tian DF; He YC; Lu FG; Tang FQ
J Zhejiang Univ Sci B; 2009 Mar; 10(3):172-9. PubMed ID: 19283871
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling and the consequent induction of transformation by overexpressed 14-3-3γ protein require specific amino acids within 14-3-3γ N-terminal variable region II.
Radhakrishnan VM; Putnam CW; Martinez JD
J Biol Chem; 2012 Dec; 287(52):43300-11. PubMed ID: 23115241
[TBL] [Abstract][Full Text] [Related]
9. Update of Natural Products and Their Derivatives Targeting Epstein-Barr Infection.
Pennisi R; Trischitta P; Costa M; Venuti A; Tamburello MP; Sciortino MT
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257824
[TBL] [Abstract][Full Text] [Related]
10. Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation.
Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
mBio; 2023 Nov; 14(6):e0233823. PubMed ID: 38009935
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and therapeutic implications of EBV-associated epithelial cancers.
Low YH; Loh CJL; Peh DYY; Chu AJM; Han S; Toh HC
Front Oncol; 2023; 13():1202117. PubMed ID: 37901329
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation.
Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
bioRxiv; 2023 Oct; ():. PubMed ID: 37090591
[TBL] [Abstract][Full Text] [Related]
13. Protein Kinase CK2 and Epstein-Barr Virus.
Montenarh M; Grässer FA; Götz C
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830895
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus: Biology and clinical disease.
Damania B; Kenney SC; Raab-Traub N
Cell; 2022 Sep; 185(20):3652-3670. PubMed ID: 36113467
[TBL] [Abstract][Full Text] [Related]
15. Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.
Kobayashi E; Kondo S; Dochi H; Moriyama-Kita M; Hirai N; Komori T; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Wakisaka N; Yoshizaki T
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740492
[TBL] [Abstract][Full Text] [Related]
16. Treatment Advances in EBV Related Lymphoproliferative Diseases.
Lv K; Yin T; Yu M; Chen Z; Zhou Y; Li F
Front Oncol; 2022; 12():838817. PubMed ID: 35515118
[TBL] [Abstract][Full Text] [Related]
17. Cancers associated with human gammaherpesviruses.
Wen KW; Wang L; Menke JR; Damania B
FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
[TBL] [Abstract][Full Text] [Related]
18. Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma.
Jia X; He Q; Zeng M; Chen Y; Liu Y
Anal Cell Pathol (Amst); 2021; 2021():6668947. PubMed ID: 34239803
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.
Cheerathodi MR; Meckes DG
Future Virol; 2018 Dec; 13(12):863-887. PubMed ID: 34079586
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
